Audience-funded nonprofit news
Next Up:
0:00
0:00
-
Listen Listen
Health
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
Sponsored message
More Stories
-
An infant infected with the highly contagious disease was at the airport last week. Here's what you need to know.
-
One clinic in South L.A. readies it's workers to deal with the possibility of immigration actions.
-
Some services will be limited as thousands of employees walk off the job, including many healthcare workers.
-
Core emergency services will remain available, but some appointments will be delayed as 20,000 employees walk off the job, including many healthcare workers.
-
The hospital received new assurances from the California attorney general to protect them as the Trump administration seeks to limit transgender healthcare for children and young adults.
-
Residents can check what stage their zone is in within the overall restoration process, as well as water quality testing data.
-
During his presidential campaign, Donald Trump distanced himself from the conservative governing plan after Democratic attacks. But now it’s increasingly viewed as a blueprint for his administration’s plans for federal health programs.
-
The hospital previously said it would pause accepting some new patients in response to a federal executive order. Now after pressure from advocates and the state, it is reversing course.
-
With a measles outbreak growing in West Texas, and isolated cases popping up across the country, experts say vaccination is the best protection. And not just for kids. Some adults may need a booster.
-
As flu rages, the Trump administration has pulled the plug on a Centers for Disease Control and Prevention flu immunization campaign that targeted high-risk groups, including pregnant women.
-
From a small station in Boyle Heights, 18-year-old Kennia Camacho talks with teens about anxiety, stress and depression.
-
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy of the weight-loss medicines it mailed to patients.
